Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparin-binding cytokines and chemokines represent a broad functional class of signaling proteins characterized by their high affinity for heparin and heparan sulfate proteoglycans (HSPGs) located on cell surfaces and within the extracellular matrix. This interaction is mediated by specific basic amino acid motifs that bind to the acidic sulfate groups of glycosaminoglycans, a process essential for the formation of stable chemotactic gradients and the protection of these proteins from proteolytic degradation. Furthermore, HSPGs often act as co-receptors, facilitating the presentation of these cytokines to their high-affinity signaling receptors to initiate biological responses such as cell migration, proliferation, and angiogenesis. In various diseases, including chronic inflammation, cancer, and transplant rejection, the dysregulation of these heparin-binding mediators drives pathological processes like excessive leukocyte recruitment and tumor vascularization. Therapeutic strategies targeting this class often utilize heparin-mimetics or non-anticoagulant heparinoids to sequester these molecules or displace them from their physiological niches, thereby modulating the immune response and inhibiting disease progression.
Competitive inhibition of glycosaminoglycan (GAG) binding, sequestration of ligands, displacement from the extracellular matrix, and inhibition of co-receptor-mediated signaling.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparin-binding cytokines and chemokines.